Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma (I-PACE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04985825 |
|
Recruitment Status :
Withdrawn
(Business decision)
First Posted : August 2, 2021
Last Update Posted : September 13, 2022
|
Sponsor:
Pega-One S.A.S.
Collaborator:
ICON plc
Information provided by (Responsible Party):
Centessa Pharmaceuticals plc ( Pega-One S.A.S. )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Actual Primary Completion Date : | August 17, 2022 |
| Actual Study Completion Date : | August 17, 2022 |